Affiliation:
1. Esperion Therapeutics, Inc. Ann Arbor Michigan USA
2. Nonclinical Pharma Solutions, LLC Dexter Michigan USA
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Reference15 articles.
1. Drug-induced QT interval prolongation: mechanisms and clinical management
2. The significance of QT interval in drug development
3. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
4. US Food and Drug Administration.Guidance for industry: S7B nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceutical use;2005.https://www.fda.gov/media/72043/download. Accessed July 29 2020.
5. US Food and Drug AdministrationGuidance for Industry: E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non‐antiarrhythmic Drugs; 2005.https://www.fda.gov/media/71372/download.Accessed July 29 2020.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献